VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675 | -10.6% | 508 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $15,301 | -54.0% | 508 | -50.5% | 0.00% | -50.0% |
| Q1 2023 | $33,241 | +12.9% | 1,027 | -0.1% | 0.01% | +14.3% |
| Q4 2022 | $29,450 | +17.8% | 1,028 | +1.6% | 0.01% | +16.7% |
| Q3 2022 | $25,000 | -10.7% | 1,012 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $28,000 | -28.2% | 1,012 | +0.1% | 0.01% | -22.2% |
| Q1 2022 | $39,000 | +21.9% | 1,011 | -0.1% | 0.01% | +12.5% |
| Q4 2021 | $32,000 | +6.7% | 1,012 | +0.9% | 0.01% | 0.0% |
| Q3 2021 | $30,000 | -18.9% | 1,003 | -9.1% | 0.01% | -20.0% |
| Q2 2021 | $37,000 | -82.2% | 1,103 | -61.0% | 0.01% | -83.9% |
| Q1 2021 | $208,000 | +845.5% | 2,827 | +371.2% | 0.06% | +785.7% |
| Q4 2020 | $22,000 | 0.0% | 600 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $22,000 | +57.1% | 600 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $14,000 | -96.9% | 600 | -96.2% | 0.01% | -96.9% |
| Q4 2019 | $456,000 | – | 15,585 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |